BHC(SH:600721) 智通财经网·2025-08-21 09:20Core Viewpoint - Baihua Pharmaceutical (600721.SH) reported a revenue of 202 million yuan for the first half of 2025, reflecting a year-on-year growth of 2.95% [1] - The net profit attributable to shareholders of the listed company reached 25.48 million yuan, marking a year-on-year increase of 12.45% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 24.06 million yuan, up by 13.82% year-on-year [1] - Basic earnings per share stood at 0.0663 yuan [1] Financial Performance - Revenue for the reporting period: 202 million yuan, up 2.95% year-on-year [1] - Net profit attributable to shareholders: 25.48 million yuan, up 12.45% year-on-year [1] - Net profit after deducting non-recurring items: 24.06 million yuan, up 13.82% year-on-year [1] - Basic earnings per share: 0.0663 yuan [1]